Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
2024's Driving Clearing Robots: Master Suggestions and Surveys - 2January’s full wolf supermoon and the Quadrantid meteor shower will start off the new year
- 3Investigate These Retreats Well known With Seniors
- 4Shas threatens to oppose 2026 state budget over haredi food-voucher exclusion
- 5Europe picks companies to help build Argonaut moon lander
- Which Film Has the Incomparable Melodic Score?
- Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence
- A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
- FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
- Doctors looking into hormone therapy as a way to ward off dementia in women
- Italy now recognizes the crime of femicide and punishes it with life in prison
- Manual for Notorious Fragrances: Immortal Aromas
- Plane Passenger Allegedly Includes ‘Bomb Threat’ in Hotspot Network Name, Forces Flight to Make Emergency Landing
- 7 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times
